Koers Henry Schein, Inc. Berne S.E.
Aandelen
HS2
US8064071025
Medische apparatuur, benodigdheden & distributie
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
- CHF | -.--% | -.--% | -.--% |
15/05 | Henry Schein zoekt overnames | CI |
15/05 | Transcript : Henry Schein, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 04:20 PM |
Omzet 2024 * | 13,36 mld. 12,21 mld. 12,32 mld. | Omzet 2025 * | 14,03 mld. 12,82 mld. 12,94 mld. | Marktkapitalisatie | 9,27 mld. 8,47 mld. 8,55 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 521 mln. 476 mln. 481 mln. | Nettowinst (verlies) 2025 * | 640 mln. 585 mln. 590 mln. | EV/omzet 2024 * | 0,84 x |
Nettoschuld 2024 * | 1,95 mld. 1,78 mld. 1,8 mld. | Nettoschuld 2025 * | 1,7 mld. 1,55 mld. 1,57 mld. | EV/omzet 2025 * | 0,78 x |
K/w-verhouding 2024 * |
18,6
x | K/w-verhouding 2025 * |
15,2
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 99,15% |
Recentste transcriptie over Henry Schein, Inc.
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Stanley Bergman
CEO | Chief Executive Officer | 74 | 01-01-80 |
Ronald South
DFI | Director of Finance/CFO | 62 | 01-01-08 |
Chief Tech/Sci/R&D Officer | 61 | 01-04-18 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Stanley Bergman
CEO | Chief Executive Officer | 74 | 01-01-80 |
Philip Laskaway
BRD | Director/Board Member | 82 | 01-02-02 |
Deborah Derby
BRD | Director/Board Member | 60 | 09-02-21 |
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,38% | 1,4 mld. | |
-9,70% | 1,36 mld. | |
-15,80% | 1,12 mld. | |
-18,17% | 859 mln. | |
-1,20% | 467 mln. | |
+2,38% | 436 mln. | |
-47,88% | 375 mln. | |
-22,48% | 343 mln. | |
-3,60% | 210 mln. |
- Beurs
- Aandelen
- Koers HSIC
- Koers HS2